Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 37 studies | 35% ± 15% | |
macrophage | 26 studies | 34% ± 21% | |
classical monocyte | 15 studies | 26% ± 10% | |
ciliated cell | 14 studies | 40% ± 15% | |
astrocyte | 14 studies | 40% ± 17% | |
microglial cell | 14 studies | 58% ± 18% | |
glutamatergic neuron | 12 studies | 58% ± 23% | |
endothelial cell of vascular tree | 12 studies | 30% ± 14% | |
monocyte | 11 studies | 37% ± 18% | |
myeloid cell | 11 studies | 42% ± 17% | |
vein endothelial cell | 11 studies | 36% ± 17% | |
mast cell | 11 studies | 30% ± 12% | |
platelet | 10 studies | 29% ± 8% | |
GABAergic neuron | 10 studies | 55% ± 21% | |
oligodendrocyte precursor cell | 10 studies | 37% ± 15% | |
natural killer cell | 9 studies | 31% ± 11% | |
endothelial cell of artery | 9 studies | 25% ± 8% | |
fibroblast | 9 studies | 25% ± 7% | |
B cell | 8 studies | 25% ± 8% | |
dendritic cell | 8 studies | 48% ± 13% | |
neuron | 8 studies | 50% ± 20% | |
epithelial cell | 8 studies | 40% ± 18% | |
basal cell | 8 studies | 46% ± 22% | |
endothelial cell of lymphatic vessel | 8 studies | 31% ± 10% | |
T cell | 7 studies | 28% ± 5% | |
non-classical monocyte | 7 studies | 26% ± 11% | |
conventional dendritic cell | 7 studies | 29% ± 12% | |
goblet cell | 7 studies | 38% ± 17% | |
interneuron | 7 studies | 57% ± 24% | |
adipocyte | 7 studies | 20% ± 5% | |
oligodendrocyte | 7 studies | 29% ± 15% | |
mononuclear phagocyte | 6 studies | 29% ± 15% | |
effector memory CD8-positive, alpha-beta T cell | 6 studies | 25% ± 9% | |
megakaryocyte | 6 studies | 60% ± 23% | |
capillary endothelial cell | 6 studies | 26% ± 11% | |
gamma-delta T cell | 6 studies | 26% ± 6% | |
myofibroblast cell | 6 studies | 30% ± 10% | |
leukocyte | 5 studies | 43% ± 20% | |
CD16-negative, CD56-bright natural killer cell, human | 5 studies | 29% ± 10% | |
pericyte | 5 studies | 30% ± 17% | |
club cell | 5 studies | 30% ± 10% | |
CD8-positive, alpha-beta T cell | 5 studies | 30% ± 10% | |
type I pneumocyte | 5 studies | 36% ± 8% | |
type II pneumocyte | 5 studies | 24% ± 5% | |
hematopoietic precursor cell | 4 studies | 29% ± 11% | |
amacrine cell | 4 studies | 23% ± 3% | |
CD16-positive, CD56-dim natural killer cell, human | 4 studies | 32% ± 8% | |
CD4-positive, alpha-beta T cell | 4 studies | 31% ± 9% | |
lymphocyte | 4 studies | 44% ± 16% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 25% ± 5% | |
mature NK T cell | 4 studies | 27% ± 15% | |
brush cell | 4 studies | 33% ± 16% | |
alveolar macrophage | 4 studies | 47% ± 21% | |
smooth muscle cell | 4 studies | 25% ± 9% | |
GABAergic interneuron | 3 studies | 57% ± 14% | |
granule cell | 3 studies | 43% ± 11% | |
retina horizontal cell | 3 studies | 25% ± 9% | |
GABAergic amacrine cell | 3 studies | 26% ± 4% | |
Mueller cell | 3 studies | 21% ± 4% | |
glycinergic amacrine cell | 3 studies | 22% ± 4% | |
abnormal cell | 3 studies | 34% ± 23% | |
hepatocyte | 3 studies | 54% ± 19% | |
ependymal cell | 3 studies | 46% ± 12% | |
enteroendocrine cell | 3 studies | 34% ± 13% | |
respiratory goblet cell | 3 studies | 40% ± 11% | |
hematopoietic stem cell | 3 studies | 33% ± 16% | |
mucus secreting cell | 3 studies | 33% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 42% ± 21% | |
lung | 9 studies | 29% ± 9% | |
peripheral blood | 4 studies | 24% ± 7% | |
liver | 4 studies | 32% ± 21% | |
placenta | 3 studies | 27% ± 10% | |
intestine | 3 studies | 22% ± 6% | |
adipose | 3 studies | 25% ± 0% | |
kidney | 3 studies | 25% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 5062.86 | 966 / 966 | 100% | 33.74 | 527 / 527 |
esophagus | 100% | 3990.17 | 1444 / 1445 | 100% | 62.17 | 183 / 183 |
stomach | 100% | 3963.54 | 359 / 359 | 100% | 38.05 | 285 / 286 |
bladder | 100% | 3890.57 | 21 / 21 | 99% | 28.59 | 501 / 504 |
lung | 100% | 5464.02 | 578 / 578 | 99% | 34.04 | 1148 / 1155 |
breast | 100% | 4654.38 | 459 / 459 | 99% | 18.90 | 1104 / 1118 |
uterus | 100% | 4023.09 | 170 / 170 | 98% | 31.23 | 452 / 459 |
ovary | 100% | 4675.99 | 180 / 180 | 98% | 17.75 | 422 / 430 |
brain | 99% | 4821.65 | 2618 / 2642 | 99% | 20.98 | 697 / 705 |
kidney | 100% | 3753.72 | 89 / 89 | 98% | 27.23 | 882 / 901 |
thymus | 100% | 3373.70 | 652 / 653 | 95% | 11.32 | 572 / 605 |
pancreas | 95% | 1683.30 | 313 / 328 | 99% | 31.65 | 176 / 178 |
adrenal gland | 100% | 4163.62 | 258 / 258 | 94% | 20.92 | 216 / 230 |
prostate | 100% | 3818.11 | 245 / 245 | 93% | 12.94 | 468 / 502 |
skin | 100% | 5299.04 | 1808 / 1809 | 90% | 11.36 | 424 / 472 |
liver | 96% | 1419.00 | 216 / 226 | 72% | 7.98 | 292 / 406 |
adipose | 100% | 5175.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 3774.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 17.60 | 1 / 1 |
peripheral blood | 99% | 4684.53 | 921 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 10.57 | 75 / 80 |
lymph node | 0% | 0 | 0 / 0 | 90% | 16.96 | 26 / 29 |
blood vessel | 89% | 1803.34 | 1184 / 1335 | 0% | 0 | 0 / 0 |
heart | 82% | 1390.46 | 702 / 861 | 0% | 0 | 0 / 0 |
muscle | 19% | 226.00 | 155 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001701 | Biological process | in utero embryonic development |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
Gene name | CMIP |
Protein name | C-Maf-inducing protein (c-Mip) (Truncated c-Maf-inducing protein) (Tc-Mip) C-Maf inducing protein |
Synonyms | TCMIP KIAA1694 |
Description | FUNCTION: Plays a role in T-cell signaling pathway. Isoform 2 may play a role in T-helper 2 (Th2) signaling pathway and seems to represent the first proximal signaling protein that links T-cell receptor-mediated signal to the activation of c-Maf Th2 specific factor. . |
Accessions | ENST00000566513.5 A0A087WUL1 ENST00000398040.8 [Q8IY22-3] Q8IY22 ENST00000537098.8 [Q8IY22-1] ENST00000539778.6 [Q8IY22-2] A0A087WU05 ENST00000566462.2 |